Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Modified Zhixiao Tongmai Ning for Preventing Radiation-Induced Kidney Injury
NCT07849088Phase 2Recruiting
- Sponsor
- Peking University First Hospital
- Start
- Aug 2026
- Primary completion
- Dec 2028
- Countries
- 1
01
Overview
A Phase 2 trial of Modified Zhixiao Tongmai Ning in acute kidney failure (AKF), sponsored by Peking University First Hospital. Started Aug 2026; status: recruiting.
02
Drugs
Modified Zhixiao Tongmai Ning
03
Conditions
acute kidney failure (AKF)
Beyond the preview
Go deeper on NCT07849088.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07849088.